Evidence map›Paper›PMID 36295654›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors.

Kei Kawada, Tomoaki Ishida, Kohei Jobu, Shumpei Morisawa, Naohisa Tamura, Shouhei Sugimoto, Masafumi Okazaki, Saburo Yoshioka, Mitsuhiko Miyamura

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kei KawadaGraduate School of Integrated Arts and Sciences, Kochi University, Kohasu, Oko Town, Nankoku City 783-8505, Japan.ORCID 0000-0003-1397-6128
Tomoaki IshidaDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Kohei JobuDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Shumpei MorisawaDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Naohisa TamuraGraduate School of Integrated Arts and Sciences, Kochi University, Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Shouhei SugimotoGraduate School of Integrated Arts and Sciences, Kochi University, Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Masafumi OkazakiDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Saburo YoshiokaGraduate School of Integrated Arts and Sciences, Kochi University, Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Mitsuhiko MiyamuraGraduate School of Integrated Arts and Sciences, Kochi University, Kohasu, Oko Town, Nankoku City 783-8505, Japan.
Kochi Medical School Hospital · JPKōchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveDasatinibFemaleGastrointestinal HemorrhageHumansImatinib MesylateMaleProtein Kinase InhibitorsPyrimidinesDasatinibImatinib MesylateProtein Kinase InhibitorsPyrimidinesBCR-ABL tyrosine kinase inhibitorchronic myeloid leukemiadasatinibgastrointestinal bleedingimatinibJapanese Adverse Drug Event Report database

Identifiers

PMID36295654
PMCPMC9609656
OpenAlexW4306937382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.